Discover the replay of this PCR Webinar on calcified lesion with E. Barbato, J. Escaned, M. McEntegart and F. Ribichini

View this replay of a LIVE Round Table Webinar - Physiology-guided PCI in bifurcations with J.F. Lassen, A. Banning and B. Faurie

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Alex Sticchi provides his take on the final results of the MAnagement of high bleeding risk patients post bioresorbable polymer coated STEnt implantion with an abbReviated versus prolonged DAPT regimen

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Thirty years after the first radial access interventional coronary procedure the RTC trial provides evidence that radial access for coronary angiography or PCI is associated with lower risks of all-cause death and bleeding compared with femoral access. Mirvat Alasnag interviews Giuseppe Gargiulo regarding the methodology and...

Aaysha Cader interviews Rania Hammami, Principal Investigator of the RIVARAD trial. They discuss the design and results of the trial which was presented during #TCT2022.

RIVARAD is the first multicentric randomized trial with 30-day RAOs as the primary endpoint, which proved the efficacy of short-term use of...

Watch Luis Ortega Paz's interview with David Berg as part of the ESC 2022 Congress coverage, and find out more about the COVID-PACT trial, which aims to study antithrombotic strategies in critically ill COVID-19 patients. Learn more about the study design (population, primary endpoint, safety criteria...)...

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Ali Nazmi Calik asks trial investigator John Alexander about the design and results of the PACIFIC-AMI phase 2 trial, which revealed no increase in bleeding versus placebo.

Pierre Deharo and Michele Pighi share with us their views on the EXIT-CALC study presented by Thomas Oomens at TCT 2022.

Aaysha Cader interviews Ganesan Karthikeyan who presented the results of INVICTUS during the ESC Congress 2022 in Barcelona: Among patients with rheumatic heart disease–associated atrial fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of cardiovascular events or death than rivaroxaban therapy,...

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Tor Biering-Sørensen talks with Aaysha Cader about the results of the DANFLU-1 trial which were presented during ESC Congress 2022 in Barcelona. In fact, elderly adults who received a high-dose quadrivalent influenza vaccine compared with a standard dose saw significantly reduced risk of death and hospitalization...

The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).

Mirvat Alasnag interviews Luigi Biasco, first author of the MitraSwiss Registry which was presented at the ESC Congress 2022 in Barcelona. Together, they discuss the enrolled population, the inclusion criteria, the design and outcomes of MitraSwiss, its comparison with other European registries and the restoration of...